PROFUND ADVISORS LLC

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1129919 BETHESDA, MD

Position in RYTM

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,865,859

-$115,926 QoQ

Shares Held

16,805

-26.3% QoQ

Ownership

0.024%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#135

of 299 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. RYTM ranks #18 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,865,859	16,805	-26.3%	Shares	Sole	2026-08-11
2026-03-31	$1,981,785	22,787	+8.3%	Shares	Sole	2026-04-27
2025-12-31	$2,252,763	21,046	+68.9%	Shares	Sole	2026-02-06
2025-09-30	$1,258,032	12,457	+10.7%	Shares	Sole	2025-11-06
2025-06-30	$711,140	11,254	-9.6%	Shares	Sole	2025-08-07
2025-03-31	$659,158	12,444	+18.7%	Shares	Sole	2025-05-08
2024-12-31	$586,726	10,481	-21.5%	Shares	Sole	2025-02-14
2024-09-30	$699,825	13,358	-4.4%	Shares	Sole	2024-11-14
2024-06-30	$573,813	13,975	-59.2%	Shares	Sole	2024-08-13
2024-03-31	$1,485,395	34,281	+67.3%	Shares	Sole	2024-05-08
2023-12-31	$941,971	20,491	-26.3%	Shares	Sole	2024-02-14
2023-09-30	$637,727	27,818	-40.9%	Shares	Sole	2023-11-13
2023-06-30	$776,349	47,080	+1.5%	Shares	Sole	2023-08-10
2023-03-31	$827,330	46,375	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.